Johnson & Johnson Innovative Medicine · 21 hours ago
Senior Financial Analyst Global Development Delivery Unit
Johnson & Johnson is a leader in healthcare innovation dedicated to improving health for humanity. The Senior Financial Analyst, Global Development Delivery Unit is responsible for budget management and business partner support, providing enhanced financial reporting and analysis on Global Development investment.
Pharmaceuticals
Responsibilities
Consolidates end-to-end Global Development spend by Therapeutic Area to enable greater insights and enhance decision-making for both areas of the business
Supports Global Development FTE forecasting and decision making, develops expertise in cross-charge model and drives greater understanding across the business
Provides functional budget and financial business partner support to the Delivery Unit Function, including forecasting, actual reporting, and proactive budget risk management
Leads quarter close activities for all Clinical Resource Organization expense and supports annual forecasting cycles for Clinical Out-of-Pocket expense
Understands and applies Johnson & Johnson’s Credo and Leadership Imperatives in day-to-day interactions with team
Qualification
Required
A minimum of a bachelor's degree is required
A minimum of three (3) years of finance or related business experience is required
Candidate must possess excellent analytical (MS Excel) and presentation (PowerPoint), conceptual, communication and interpersonal skills, required
The ability to think creatively and work in a team environment is required
Individual must work well in a dynamic environment and be able to drive improved processes, work independently and prioritize multiple tasks required
Preferred
Accounting or Finance degree
CPA, CMA, MBA or other financial certification
Experience in the pharmaceutical or medical device industry
Company
Johnson & Johnson Innovative Medicine
Johnson and Johnson Innovative Medicine focuses on developing medical solutions for some of the challenging diseases and medical conditions.
Funding
Current Stage
Late StageRecent News
2025-08-14
Company data provided by crunchbase